These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28823390)

  • 1. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
    Bishop EJ; Tiruvoipati R; Metcalfe J; Marshall C; Botha J; Kelley PG
    Intern Med J; 2018 Jun; 48(6):651-660. PubMed ID: 29363242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Clostridium difficile infection in a French university hospital.
    Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
    Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.
    Pichenot M; Héquette-Ruz R; Le Guern R; Grandbastien B; Charlet C; Wallet F; Schiettecatte S; Loeuillet F; Guery B; Galperine T
    Infection; 2017 Aug; 45(4):425-431. PubMed ID: 28120176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study.
    Kobayashi K; Sekiya N; Ainoda Y; Kurai H; Imamura A
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1947-1953. PubMed ID: 28577158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
    Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
    J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
    Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of removing metronidazole from treatment armamentarium of mild acute
    Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
    Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
    [No Abstract]   [Full Text] [Related]  

  • 20. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.